HL Letrozole 2,5 mg (Femara)

Letrozole 2,5 mg (Femara)

Manufacturer : Hutech Labs

Category : Oral

Dose and quantity : 2.5 mg/tablet

Packaging : 50 tablets

Form : Oral

Active substance : Letrozole

Active half-life : 2 days

Classification : Aromatase inhibitor

Dosage : 0.25-0.5 mg daily

Water retention : No

Aromatization : No

The medication letrozole, commonly referred to as Letro, is mostly recommended to postmenopausal women in order to treat breast cancer. Because of its efficacy in preventing breast cancer, it is becoming more and more popular among those wishing to purchase steroids online. Letrozole is a member of the aromatase inhibitor medication class. It works by inhibiting the enzyme aromatase, which stops the body from converting androgens into estrogens.

This medication functions by lowering the body's estrogen levels. Letrozole prevents the growth of breast cancer cells that require estrogen for development by inhibiting the aromatase enzyme, which is responsible for turning androgens into estrogens.

Letrozole is mostly used to treat postmenopausal women for breast cancer, but it can also be used to treat infertility in women who have disorders such polycystic ovary syndrome or infertility that is not explained.

Letrozole 2.5 mg once a day, taken orally, with or without food, is the suggested dosage.

In comparison to other medications like tamoxifen, letrozole 2.5 mg has the advantage of suppressing the growth of breast cancer cells, improving the chances of conception for PCOS women, treating hormone receptor-positive metastatic breast cancer, lowering the risk of cancer recurrence following surgery or other treatments, and having a lower chance of causing blood clots. It can also be used to treat premenopausal women with breast cancer as an alternative to surgically removing the ovaries.

Letrozole may cause hot flashes, headaches, nausea, exhaustion, joint discomfort, dry vagina, and an elevated risk of osteoporosis, heart disease and stroke.